je.st
news
Tag: application
Millimeter Wave Technology Market By Product, Frequency Bands, Component, Application, And Geography - Forecast To 2020
2015-07-02 09:14:12| rfglobalnet Home Page
A millimeter wave is a special electromagnetic wave with a frequency range between 20 GHz and 300 GHz. In the context of wireless communication, MM waves are generally referred to as bands of spectrum of around 38 GHz, 60 GHz, and 94 GHz.
Tags: to
product
technology
market
JAG 2015 Application
2015-07-02 00:07:13| PortlandOnline
PDF Document, 4,255kbCategory: Fiscal Services Divsion
Tags: application
jag
LED Luminaire meets roadway lighting application requirements.
2015-07-01 14:31:06| Industrial Newsroom - All News for Today
Able to replace 50–150 W high pressure sodium fixtures, Streetworks Verdeon™ LED Roadway Luminaire employs AccuLED Optics™ technology and supports various control options. Range of lumen packages, delivering up to 109 lm/W, are available, and luminaire comes in 4000K CCT and 70 CRI; 3000K and 6000K CCT options are also available. Supporting photocontrol- and motion-based dimming options, luminaire comes in die-cast aluminum housing and is UL wet location listed.
Tags: application
requirements
led
lighting
Rugged Tablet Bundles survive utility application environments.
2015-07-01 14:31:05| Industrial Newsroom - All News for Today
Standard configuration of 2.73 lb DURABOOK R11 (ER11H0-52BM408J3) is powered by fourth generation Intel® Haswell Core™ i5 CPU with 4 GB DDR3. Construction is certified to MIL-STD-810G, MIL-STD- 461F, and IP65, and widescreen display has 11.6 in. diagonal. Along with 128 GB SSD, features include 802.11ac/a/b/g/n wireless and Bluetooth® 4.0, front panel HD webcam, and 5 MP rear camera. Capacitive multi-touch sunlight panel can be used in wet environments and/or while wearing latex gloves.
Tags: application
utility
environments
survive
MM-398 Receiving The Priority Review Designation By US FDA For New Drug Application And The Acceptance Of Market Authorization Application By EMA In Post-Gemcitabine Metastatic Pancreatic Cancer
2015-07-01 08:52:42| drugdiscoveryonline Home Page
PharmaEngine, Inc. (TWO: 4162) announced that (1) its license partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), has received the notification from the US Food and Drug Administration (FDA) for the acceptance and the grant of the priority review designation for their New Drug Application (NDA); and (2) its sublicense partner, Baxalta Incorporated, a wholly owned subsidiary of Baxter International Inc. (NYSE: BAX) has received the acceptance of Market Authorization Application (MAA) from the European Medicines Agency (EMA), of MM-398 (irinotecan liposome injection, also known as "nal-IRI,") in the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy
Tags: review
market
application
drug
Sites : [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] next »